Healthy Skepticism Library
Items published during the years 1980 to 1989
There are 1082 items in the Healthy Skepticism Library that were published during the years 1980 to 1989.
Page 10 of 11 pages ‹ First < 8 9 10 11 >
HSL8459
Laitin JA, Getyer EG.
Borrowing a European success: prescription pad advertising
Pharmaceutical Executive 1982 Dec; 2:38-39
HSL3115
O'Malley K, O'Hanrahan M.
Drug promotion and the doctor.
Br J Clin Pharmacol 1982 Nov; 14:(5):661-4
HSL3120
Snell ES.
Drug promotion and the doctor--a reply.
Br J Clin Pharmacol 1982 Nov; 14:(5):664-6
HSL3117
Rochmis PG.
Seminars for physicians.
JAMA 1982 Oct 1; 248:(13):1580-1
HSL3129
Kushner D.
Two-thirds of RPh's & MD's object to makers' promotion of Rx drugs to the public
American Druggist 1982 Oct; 186:(1):14, 16, 21-22
HSL8457
Buc NL.
Current regulatory issues in marketing prescription drugs: comparative claims and advertising to consumers
Food Drug Cosmet Law J 1982 Oct; 37:402-408
HSL8458
Two-thirds of RPh's and MD's object to makers' promotion of Rx drugs to the public
American Druggist 1982 Oct; 186:14, 16, 21-22
HSL8460
Lubman S.
Is patent extension necessary?
Pharmaceutical Technology 1982 Oct; 6:26-27
HSL8463
Oliver C.
Made in New York: good prescription for the pharmaceutical industry
Pharmaceutical Executive 1982 Oct; 2:56, 60
HSL8466
Chain pharmacists are found more likely than indeps to use unbranded generics
American Druggist 1982 Oct; 186:13, 70, 72, 76, 79, 82, 86, 88
HSL19896
Lasagna L
Book Review: Prescriptions for Death: The Drugging of the Third World
NEJM 1982 Sep 23; 830
HSL16706
Wolfe S
Oraflex: Who Learned?
The Washington Post 1982 Sep 20
HSL8469
Prescription drugs; revocation of final guideline patient package inserts and withdrawal of draft guideline patient package inserts--Food and Drug Administration.
Fed Regist 1982 Sep 7; 47:(173):39249-50
HSL3099
Bainbridge CV, D'Ambrosio GG, Petrick RJ, Weiss EM.
Pharmaceutical manufacturer's responses to drug information inquiries.
Am J Hosp Pharm 1982 Sep; 39:(9):1532-4
HSL16703
Wolfe, S
Benoxaprofen
BMJ 1982 Sep; 285:(6344):809
HSL3128
Budiansky S.
Drug promotion: FDA steps in
Nature 1982 Aug 26; 298:784-785
HSL8461
Hager T.
Therapeutic substitution: drawing the battle lines
Pharmaceutical Executive 1982 Aug; 2:59-62
HSL20039
King K
Doctors and drug companies
MJA 1982 July 24; 63
HSL2065
Avorn J, Chen M, Hartley R.
Scientific versus commercial sources of influence on the prescribing behavior of physicians.
Am J Med 1982 Jul; 73:(1):4-8
HSL3107
Hatton RC, Doering PL, Frias JL.
Physicians' sources of information about teratogenic effects of drugs.
Drug Inf J 1982 Jul-Sep; 16:(3):148-53
HSL3127
McGhan W, Seery S, Hill B, Koda R.
Hospital pharmacists' attitudes towards medical services representatives: a comparison of directors, staff, and clinical pharmacists.
Hosp Formul 1982 Jul; 17:(7):957-61
HSL8468
Medicines Act 1968: procedure drawn up for pursuing changes in legal status of medicines
Pharmaceutical Journal 1982 Jul; 229:54-55
HSL8467
Prescription of generics and the pharmaceutical industry
Cienc Ind Farm 1982 Jun; 1:217
HSL8471
Klein T.
Going public: promoting prescription drugs to consumers
Pharmaceutical Executive 1982 Jun; 2:46, 50, 52
HSL8472
Meyers HM.
Packaging: will advertising change prescription drug labeling?
Pharmaceutical Executive 1982 Jun; 2:44-45
HSL8470
Gunston G.
Pharmaceutical marketing: predicting prescribing response
Pharmaceutical Journal 1982 May 29; 228:619-620
HSL3126
The WHO and the pharmaceutical industry
1982 May 01;
HSL3102
Cohn JN.
Science and advertising.
Circulation 1982 May; 65:(5):839-40
HSL3123
Strickland-Hodge B, Jepson MH.
Identification and characterization of early and late prescribers in general practice.
J R Soc Med 1982 May; 75:(5):341-5
HSL8473
Accept no substitutes
Pharmaceutical Journal 1982 Apr 17; 28:440-441
HSL3121
Soffer A.
Free medical publications or scientific medical journals.
Chest 1982 Apr; 81:(4):397-8
HSL3124
Tse CS.
Disclosure of product information by manufacturers.
Am J Hosp Pharm 1982 Apr; 39:(4):645-6
HSL8526
Meadows RJ.
Prospectus on new drugs
Drug Merchandising 1982 Apr; 63:18-19
HSL8528
Gunston G.
Pharmaceutical marketing: kill or cure?
Pharmaceutical Journal 1982 Mar 20; 228:350
HSL13326
Zelino R.
The Interaction among the Criteria Physicians Use When Prescribing
Medical Care 1982 Mar; 20:(3):277-85
http://www.lww-medicalcare.com/pt/re/medcare/issuelist.htm
HSL16704
Wolfe SM.
Mis-prescribing: causes and remedies.
Internist 1982 Feb; 23:(1):8-10
http://www.ncbi.nlm.nih.gov/pubmed/10257494
HSL3114
O'Brien WM.
Alleged direct promotion of prescription drugs to consumers.
N Engl J Med 1982 Jan 21; 306:(3):181-2
HSL2075
Kahneman D, Slovic P, Tversky A.
Judgment under uncertainty: heuristics and biases.
New York: Cambridge University Press 1982
http://www.cambridge.org/uk/catalogue/catalogue.asp?isbn=0521284147
HSL2143
Haayer F.
Rational prescribing and sources of information.
Soc Sci Med 1982; 16:(23):2017-23
HSL2714
Buc N.
Current regulatory issues in marketing prescription drugs: Comparative claims and advertising to consumers
Food Drug Cosmetic Law Journal 1982; 37:402-408
HSL3096
Drugs and the Third World
Lancet 1982; 2:1351
HSL3098
Publicity and the public’s ‘right to know’
New Zealand Pharmacy 1982; 2:(6):19, 22
HSL3100
Blum A.
The subject of advertising
Medical Journal of Australia 1982; 2:61
HSL3101
Bourbonniere C.
Ethical issues in sponsorship of CME
Canadian Medical Association Journal 1982; 127:681
HSL3103
Cooperstock R, Hill J.
The effects of tranquillization: benzodiazepine use in Canada
Health and Welfare Canada 1982;
HSL3104
Defesche CL.
Alleged direct promotion of prescription drugs to consumers
New England Journal of Medicine 1982; 306:182
HSL3105
Dunn E, William JI, Bryans AM, Davis D, Delmore T, Herron A, Krauser J, Scott DJ.
Continuing medical education in Ontario: a primary care perspective
Canadian Family Physician 1982; 28:1327-1333
HSL3106
Gass DA.
Ethical issues in sponsorship of CME
Canadian Medical Association Journal 1982; 127:681
HSL3108
Lanier B.
Drug company advertising to the public
JAMA 1982; 248:1163
HSL3109
McMillan JH.
Information about medicines
New Zealand Medical Journal 1982; 95:674-675
HSL3110
Medawar C.
Marketing and use of pharmaceuticals—bad information means bad medicine
1982;
HSL3111
Melrose D.
Bitter pills: medicines and the Third World poor
1982;
http://publications.oxfam.org.uk/oxfam/display.asp?K=9780855980658&cat=090,280&ob=SORT_DATE/d&m=43&dc=220
HSL3112
Melville A, Johnson C.
Cured to death: the effects of prescription drugs
1982;
HSL3113
Muller M.
The health of nations: a north-south investigation
: Faber and Faber 1982
HSL3116
Rheinstein PH.
A head start, a broader audience, and an emphasis on difference: The new frontiers of prescription drug promotion
Food Drug Cosmetic Law Journal 1982; 37:330-335
HSL3118
Silverman M, Lee PR, Lydecker M.
The drugging of the Third World.
Int J Health Serv 1982; 12:(4):585-96
HSL3119
Silverman M, Lee PR, Lydecker M.
Prescriptions for death: the drugging of the Third World
Berkeley: University of California Press 1982;
HSL3122
Soffer A.
Hazards in publication of proceedings
Archives of Internal Medicine 1982; 142:2074-2076
HSL3125
Victora CG.
Statistical malpractice in drug promotion: a case-study from Brazil.
Soc Sci Med 1982; 16:(6):707-9
HSL5382
US Congress, Office of Technology Assessment
Postmarketing Surveillance of Prescription Drugs
Washington, DC: US Government Publishing Office 1982
HSL8454
Williams P.
Cost of tranquilizers
Social Science and Medicine 1982; 16:(22):1955-1958
HSL9075
Medawar C, Freese B.
Drug Diplomacy
London: Social Audit 1982
http://www.socialaudit.org.uk/122order.htm#1.22%20How%20to%20order
HSL12508
Jones S.
Social marketing: dimensions of power and politics.
Eur J Mark 1982; 16:(6):46-53
http://www.ncbi.nlm.nih.gov/pubmed/12280422
HSL13275
Hadsall RS, Freeman RA, Norwood GJ.
Factors related to the prescribing of selected psychotropic drugs by primary care physicians.
Soc Sci Med 1982; 16:(20):1747-56
http://www.ncbi.nlm.nih.gov/pubmed/7178921
HSL16705
Wolfe SM.
The marketing of a drug.
Health Med 1982 Spr; 1:(2):31-2
http://www.ncbi.nlm.nih.gov/pubmed/10257087
HSL8465
Baum C, Rheinstein P.
It is time to change the brief summary?
Pharmaceutical Executive 1981 Nov; 1:34, 36, 38-39
HSL3094
Richter R.
Pesticides and pills: for export only Part two: pharmaceuticals
1981 Oct 24;
HSL3095
Freese B, Medawar C, Herxheimer A.
No more lomotil for infants.
Lancet 1981 Oct 10; 2:(8250):816-7
HSL8532
Kushner D.
Growing substitution in chains: how will innovating firms respond?
American Druggist 1981 Oct; 184:3, 52, 54, 58, 60, 62, 66, 68,
HSL3093
Pazderka B, Rao RC.
Market share competition in the Canadian prescription drug industry: a comparison of several therapeutical markets
1981 Sep;
HSL8464
Thomas WH.
Substitution and generic products
New Zealand Pharmacy 1981 Sep; 1:35-37, 43
HSL3079
Koumjian K.
The use of valium as a form of social control.
Soc Sci Med [E] 1981 Aug; 15:(3):245-9
HSL8474
Rheinstein PH.
Advertising prescription drugs-first promotional campaign
Drug Information Journal 1981 Jul-Dec; 15:125-127
HSL8529
Vertes L.
Interactions of oral antidiabetics
Gyogyszereszet 1981 Jul; 25:242-243
HSL3083
Oppenheim GL, Erickson SH, Ashworth C.
The family physician's knowledge of the cost of prescribed drugs.
J Fam Pract 1981 Jun; 12:(6):1027-30
HSL8531
Chiles VK.
Self-medication triangle: manufacturer, pharmacist and consumer
Canadian Pharmaceutical Journal 1981 Jun; 114:220-221, 228
HSL8538
Feldmann EG.
Preclearance of drug products--pharmacy's perspective.
Am Pharm 1981 Jun; NS21:(6):26-32
HSL3092
Culliton BJ.
Biomedical research enters the marketplace
New England Journal of Medicine 1981 May 14; 304:(20):1195-1201
HSL3063
Christensen DB, Bush PJ.
Drug prescribing: patterns, problems and proposals.
Soc Sci Med [A] 1981 May; 15:(3):
HSL8536
Tidball P.
The pharmaceutical industry's responsibilities in the prescription process.
Can Pharm J 1981 May; 114:(5):177-9
HSL8475
Generic Rxs rise by 5.9% as branded Rxs increase by only 1.6%
Pharmacy Times 1981 Apr; 47:17-25
HSL8537
Martucci HJ, Parry MF.
Cephalosporin cost reduction.
Hosp Formul 1981 Apr; 16:(4):396-8,
HSL3064
Curry L, Putnam RW.
Continuing medical education in Maritime Canada: the methods physicians use, would prefer and find most effective.
Can Med Assoc J 1981 Mar 1; 124:(5):563-6
HSL8530
Pharmacy and manufacturer relations
Apothecary 1981 Mar; 93:10-17
HSL8540
Strickland HODGE, Jepson MH.
Typing prescribers by reaction to medical detailing
Chemist and Druggist 1981 Feb 21; 215:346, 352
HSL8535
Dickinson JG.
Reagan era and pharmacy
Drug Topics 1981 Feb 20; 125:40-43
HSL3075
Hemminki E.
Quality of reports of clinical trials submitted by the drug industry to the Finnish and Swedish control authorities.
Eur J Clin Pharmacol 1981 Feb; 19:(3):157-65
HSL3089
Pharmaceutical prices in Canada: guiding principles for government policy
Pharmaceutical Manufacturers Association of Canada 1981 Feb;
HSL3074
Gustafsson LL, Wide K.
Marketing of obsolete antibiotics in Central America.
Lancet 1981 Jan 3; 1:(8210):31-3
HSL18712
Friedman JA, Alkhateeb W
Exporting Exploitation: The Dumping of U. Banned Pharmaceuticals in LDC's
Int Q Community Health Educ 1981 Jan 1; 2:(4):289-99
http://www.ncbi.nlm.nih.gov/pubmed/20841092
HSL2087
Fazio RH, Zanna MP.
Direct experience and attitude-behavior consistency.
Berkowitz L. Advances in experimental social psychology New York: Academic Press 1981
http://www.amazon.co.uk/exec/obidos/ASIN/0120152134/qid=1124174696/sr=8-5/ref=sr_8_xs_ap_i5_xgl/026-3368758-1517268
HSL3060
Journal IN.
Lancet 1981; 2:801
HSL3061
Berry EM.
The evolution of scientific and medical journals
New England Journal of Medicine 1981; 305:400-402
HSL3062
Blum R, Kreitman K.
Factors affecting individual use of medicines
1981; 122-185
HSL3065
Goldbloom D.
Drug companies and medical education: a modest proposal
McGill Medical Journal 1981; 46:(2):24
HSL3076
Hibberd PL, Meadows AJ.
The pharmaceutical industry as a provider of drug information
Journal of Research Communication Studies 1981; 3:289-297
HSL3077
Hymans R.
NZ Institute of Medical Representatives
New Zealand Medical Journal 1981; 94:11
HSL3078
Jayasuriya DC.
Regulating the drug trade in the Third World
World Health Forum 1981; 2:423-426
HSL3080
Leffler KB.
Persuasion or information? The economics of prescription drug advertising
Journal of Law and Economics 1981; 24:45-74
HSL3081
Mark JA, Honigman B.
The weight of evidence
New England Journal of Medicine 1981; 305:175
Page 10 of 11 pages ‹ First < 8 9 10 11 >
